Related Experiment Videos
Insights
Childhood cancer is rare, often affecting those under 5. While causes remain unknown, significant treatment advances mean 60% of pediatric cancer patients diagnosed in the 1990s achieved a cure.
Area of Science:
- Pediatric Oncology
- Childhood Malignancies
Background:
- Childhood cancer is uncommon, with most cases occurring in children under 5.
- Common pediatric tumors involve bone marrow, lymphoid systems, and the central nervous system.
- Solid tumors in children are typically sarcomas, while carcinomas are rare.
Purpose of the Study:
- To summarize the characteristics and outcomes of childhood cancers.
- To highlight advancements in pediatric cancer treatment.
Main Methods:
- Review of epidemiological data on pediatric malignancies.
- Analysis of treatment outcomes for childhood cancers.
Main Results:
- The majority of pediatric malignancies occur in children under 5 years old.
- Bone marrow, lymphoid system, and central nervous system tumors are most common.
- Survival rates have improved, with 60% of children diagnosed in the 1990s being cured.
Conclusions:
- Despite unknown causes and lack of preventive measures, significant progress has been made in treating childhood cancers.
- Improved survival rates indicate successful advancements in pediatric cancer care.
Abstract:
Cancer is an uncommon disease in children. The majority of children who develop a malignancy are under the age of 5 years with the commonest tumours being those of the bone marrow, lymphoid systems and central nervous system. Solid tumours in children are almost always sarcomas. Tumours of epithelial origin (or carcinomas) are exceedingly rare. The cause of the various paediatric cancers is largely unknown, and preventive measures are therefore unavailable to combat them. Despite this, there have been significant gains made in the past 20 years, such that 60% of all children who present with a malignancy in the 1990s can expect to be cured.